- HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio
- HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG
- HeartSciences to Present at the LD Micro Invitational XIV Conference
- HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients
- HeartSciences Reports Third Quarter Fiscal 2024 Financial Results
- HeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes
- HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology
- HeartSciences Adds Key Advisor to its Scientific Advisory Board
- HeartSciences Expands its Scientific Advisory Board
- HeartSciences Appoints New Scientific Advisory Board Member
More ▼
Key statistics
On Friday, Heart Test Laboratories Inc (HSCS:NAQ) closed at 5.50, 5.57% above its 52-week low of 5.21, set on May 23, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.49 |
---|---|
High | 6.81 |
Low | 5.46 |
Bid | 5.65 |
Offer | 5.80 |
Previous close | 6.81 |
Average volume | 129.81k |
---|---|
Shares outstanding | 655.62k |
Free float | 550.66k |
P/E (TTM) | -- |
Market cap | 3.61m USD |
EPS (TTM) | -0.4912 USD |
Data delayed at least 15 minutes, as of May 31 2024 21:00 BST.
More ▼